- Home
- DTST vs RVPH Comparison
DTST vs RVPH Comparison
Compare DTST & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- RVPH
- Stock Information
- Founded
- DTST 2001
- RVPH 2006
- Country
- DTST United States
- RVPH United States
- Employees
- DTST N/A
- RVPH N/A
- Industry
- DTST EDP Services
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- RVPH Health Care
- Exchange
- DTST Nasdaq
- RVPH Nasdaq
- Market Cap
- DTST 28.5M
- RVPH 33.4M
- IPO Year
- DTST N/A
- RVPH N/A
- Fundamental
- Price
- DTST $3.92
- RVPH $1.24
- Analyst Decision
- DTST
- RVPH Strong Buy
- Analyst Count
- DTST 0
- RVPH 4
- Target Price
- DTST N/A
- RVPH $15.33
- AVG Volume (30 Days)
- DTST 74.9K
- RVPH 656.8K
- Earning Date
- DTST 11-14-2024
- RVPH 11-14-2024
- Dividend Yield
- DTST N/A
- RVPH N/A
- EPS Growth
- DTST N/A
- RVPH N/A
- EPS
- DTST 0.02
- RVPH N/A
- Revenue
- DTST $25,143,911.00
- RVPH N/A
- Revenue This Year
- DTST $8.30
- RVPH N/A
- Revenue Next Year
- DTST $11.32
- RVPH N/A
- P/E Ratio
- DTST $194.72
- RVPH N/A
- Revenue Growth
- DTST 1.64
- RVPH N/A
- 52 Week Low
- DTST $2.75
- RVPH $0.60
- 52 Week High
- DTST $8.00
- RVPH $5.67
- Technical
- Relative Strength Index (RSI)
- DTST 50.97
- RVPH 54.13
- Support Level
- DTST $3.70
- RVPH $1.09
- Resistance Level
- DTST $4.34
- RVPH $1.37
- Average True Range (ATR)
- DTST 0.40
- RVPH 0.15
- MACD
- DTST -0.02
- RVPH 0.03
- Stochastic Oscillator
- DTST 28.89
- RVPH 63.16
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.